To add your name to our petition, please read the statement and fill in the form below. We will not make your name or details publicly available online.

We, the undersigned, disagree with the decision by the National Institute of Health and Clinical Excellence (NICE), on 21st August 2006, to deny NHS patients, with advanced bowel cancer, the option to be treated with Avastin (bevacizumab) or Erbitux (cetuximab), on the basis of cost-effectiveness.

We believe that NICE should reconsider its decision, taking into consideration the huge value for patients, and their close family and friends, which is gained from additional months of quality life offered by these treatments, or the reduction of patients' tumour sizes to enable further treatment options which could potentially offer the chance of remission.

We support Beating Bowel Cancer in their mission to ensure open access to the newest and best treatments for bowel cancer patients, regardless of where someone lives or their ability to pay.

Privacy Policy

If you opt-in to join our mailing list, we will use your personal information to communicate with you and tell you about our charitable work for patients with bowel cancer.

We may use it to send emails to you and information such as our tri-annual newsletter. We may use it to notify you of the campaigns that we are running and our fundraising activities and to seek your support with these. We may use it to provide services to you that you have specifically requested from us or to deliver products to you that you have ordered from us.

We do not share, sell, rent or lease the information we collect to any third parties and we do not use or disclose information of a sensitive nature such as information about any disability that you might have, your race, religion, or political affiliations, without firstly obtaining your explicit consent.